
Di Xiao
Examiner (ID: 13777, Phone: (571)270-1758 , Office: P/2141 )
| Most Active Art Unit | 2141 |
| Art Unit(s) | 2179, 2175, 2178, 2141 |
| Total Applications | 667 |
| Issued Applications | 485 |
| Pending Applications | 71 |
| Abandoned Applications | 138 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14566735
[patent_doc_number] => 20190210974
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-11
[patent_title] => DIARYLHYDANTOIN COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/229904
[patent_app_country] => US
[patent_app_date] => 2018-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32961
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16229904
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/229904 | DIARYLHYDANTOIN COMPOUNDS | Dec 20, 2018 | Abandoned |
Array
(
[id] => 18852701
[patent_doc_number] => 11850253
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-12-26
[patent_title] => Two component compositions
[patent_app_type] => utility
[patent_app_number] => 16/956137
[patent_app_country] => US
[patent_app_date] => 2018-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7299
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 219
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16956137
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/956137 | Two component compositions | Dec 19, 2018 | Issued |
Array
(
[id] => 14227117
[patent_doc_number] => 20190125731
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-02
[patent_title] => ANTIFIBROTIC COMPOUNDS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/224442
[patent_app_country] => US
[patent_app_date] => 2018-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17565
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16224442
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/224442 | ANTIFIBROTIC COMPOUNDS AND USES THEREOF | Dec 17, 2018 | Abandoned |
Array
(
[id] => 15143459
[patent_doc_number] => 20190350207
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-21
[patent_title] => COMPOSITIONS AND METHODS USEFUL FOR THE PREVENTION OF MALARIA AND DENGUE VIRUS TRANSMISSION
[patent_app_type] => utility
[patent_app_number] => 16/223314
[patent_app_country] => US
[patent_app_date] => 2018-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15246
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16223314
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/223314 | Compositions and methods useful for the prevention of malaria and dengue virus transmission | Dec 17, 2018 | Issued |
Array
(
[id] => 17889765
[patent_doc_number] => 11452712
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-27
[patent_title] => Methods and compositions involving (S)-bucindolol
[patent_app_type] => utility
[patent_app_number] => 16/219722
[patent_app_country] => US
[patent_app_date] => 2018-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 17
[patent_no_of_words] => 16461
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16219722
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/219722 | Methods and compositions involving (S)-bucindolol | Dec 12, 2018 | Issued |
Array
(
[id] => 14160863
[patent_doc_number] => 20190107534
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-11
[patent_title] => AZETIDINE-SUBSTITUTED FLUORESCENT COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/211388
[patent_app_country] => US
[patent_app_date] => 2018-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31865
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 428
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16211388
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/211388 | Azetidine-substituted fluorescent compounds | Dec 5, 2018 | Issued |
Array
(
[id] => 15663995
[patent_doc_number] => 10596205
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-24
[patent_title] => Topical medicament for skin and mucosal injuries
[patent_app_type] => utility
[patent_app_number] => 16/211179
[patent_app_country] => US
[patent_app_date] => 2018-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9220
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 150
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16211179
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/211179 | Topical medicament for skin and mucosal injuries | Dec 4, 2018 | Issued |
Array
(
[id] => 15449297
[patent_doc_number] => 10548879
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-02-04
[patent_title] => (2R,4R)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid
[patent_app_type] => utility
[patent_app_number] => 16/207501
[patent_app_country] => US
[patent_app_date] => 2018-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 21715
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16207501
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/207501 | (2R,4R)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid | Dec 2, 2018 | Issued |
Array
(
[id] => 16824153
[patent_doc_number] => 20210139446
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-13
[patent_title] => PROCESS FOR THE SEPARATION OF GALLATED EPICATECHINS (EGCG & ECG) FROM GREEN TEA EXTRACT OR GREEN TEA DUST
[patent_app_type] => utility
[patent_app_number] => 16/769853
[patent_app_country] => US
[patent_app_date] => 2018-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5291
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16769853
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/769853 | Process for the separation of gallated epicatechins (EGCG and ECG) from green tea extract or green tea dust | Nov 25, 2018 | Issued |
Array
(
[id] => 14403815
[patent_doc_number] => 20190167751
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-06
[patent_title] => DIETARY SUPPLEMENT COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 16/198121
[patent_app_country] => US
[patent_app_date] => 2018-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3399
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16198121
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/198121 | Dietary supplement compositions | Nov 20, 2018 | Issued |
Array
(
[id] => 17355277
[patent_doc_number] => 20220016073
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-20
[patent_title] => COMPOSITION FOR PREVENTING OR TREATING NEURODEGENERATIVE DISEASES, CONTAINING DITERPENE-BASED COMPOUND
[patent_app_type] => utility
[patent_app_number] => 16/763630
[patent_app_country] => US
[patent_app_date] => 2018-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10017
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16763630
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/763630 | COMPOSITION FOR PREVENTING OR TREATING NEURODEGENERATIVE DISEASES, CONTAINING DITERPENE-BASED COMPOUND | Nov 14, 2018 | Abandoned |
Array
(
[id] => 18152003
[patent_doc_number] => 11564953
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-31
[patent_title] => Ionizing irradiation sterilization of bacterial minicell-based biopharmaceuticals and methods of use
[patent_app_type] => utility
[patent_app_number] => 16/186290
[patent_app_country] => US
[patent_app_date] => 2018-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 16
[patent_no_of_words] => 22917
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16186290
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/186290 | Ionizing irradiation sterilization of bacterial minicell-based biopharmaceuticals and methods of use | Nov 8, 2018 | Issued |
Array
(
[id] => 17748236
[patent_doc_number] => 20220226439
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => METHODS OF REDUCING SIDE EFFECTS OF ANTI-CD30 ANTIBODY DRUG CONJUGATE THERAPY
[patent_app_type] => utility
[patent_app_number] => 16/760916
[patent_app_country] => US
[patent_app_date] => 2018-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17324
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -43
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16760916
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/760916 | METHODS OF REDUCING SIDE EFFECTS OF ANTI-CD30 ANTIBODY DRUG CONJUGATE THERAPY | Oct 31, 2018 | Abandoned |
Array
(
[id] => 16695422
[patent_doc_number] => 10945991
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-16
[patent_title] => Use and pharmaceutical composition for liver fibrosis prevention and/or treatment
[patent_app_type] => utility
[patent_app_number] => 16/173243
[patent_app_country] => US
[patent_app_date] => 2018-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 6202
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16173243
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/173243 | Use and pharmaceutical composition for liver fibrosis prevention and/or treatment | Oct 28, 2018 | Issued |
Array
(
[id] => 14130693
[patent_doc_number] => 20190099736
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-04
[patent_title] => Methods for Using Bentonite to Remove Pesticides from Cannabinoid Extract Oils
[patent_app_type] => utility
[patent_app_number] => 16/151277
[patent_app_country] => US
[patent_app_date] => 2018-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16827
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16151277
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/151277 | Methods for using bentonite to remove pesticides from cannabinoid extract oils | Oct 2, 2018 | Issued |
Array
(
[id] => 14277069
[patent_doc_number] => 20190135819
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-09
[patent_title] => CARM1 INHIBITORS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/149519
[patent_app_country] => US
[patent_app_date] => 2018-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 64897
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16149519
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/149519 | CARM1 inhibitors and uses thereof | Oct 1, 2018 | Issued |
Array
(
[id] => 14913579
[patent_doc_number] => 10428095
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-10-01
[patent_title] => Compounds for treatment of complement mediated disorders
[patent_app_type] => utility
[patent_app_number] => 16/148622
[patent_app_country] => US
[patent_app_date] => 2018-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26548
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16148622
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/148622 | Compounds for treatment of complement mediated disorders | Sep 30, 2018 | Issued |
Array
(
[id] => 14913545
[patent_doc_number] => 10428078
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-10-01
[patent_title] => Compounds
[patent_app_type] => utility
[patent_app_number] => 16/143788
[patent_app_country] => US
[patent_app_date] => 2018-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 92837
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 446
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16143788
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/143788 | Compounds | Sep 26, 2018 | Issued |
Array
(
[id] => 13840489
[patent_doc_number] => 20190023729
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-24
[patent_title] => ARYL, HETEROARYL, AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/140148
[patent_app_country] => US
[patent_app_date] => 2018-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30327
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 383
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16140148
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/140148 | Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders | Sep 23, 2018 | Issued |
Array
(
[id] => 15880223
[patent_doc_number] => 10646434
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-05-12
[patent_title] => Hypotonic microbicidal formulations and methods of use
[patent_app_type] => utility
[patent_app_number] => 16/123278
[patent_app_country] => US
[patent_app_date] => 2018-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 11136
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16123278
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/123278 | Hypotonic microbicidal formulations and methods of use | Sep 5, 2018 | Issued |